JENNA LOCAPUTO: Open Payments
NPI 1740614890 · ALBANY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$796 in 46 payments from 12 companies in 2025. Trend: 2023 $766 · 2024 $695 · 2025 $796
Food & beverage: $796
| Company | Payments | Amount |
|---|---|---|
| CSL Behring | 11 | $210 |
| GlaxoSmithKline, LLC. | 14 | $168 |
| Regeneron Healthcare Solutions, Inc. | 5 | $115 |
| GENZYME CORPORATION | 3 | $77 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $49 |
| Axsome Therapeutics, Inc. | 3 | $48 |
| JAZZ PHARMACEUTICALS INC. | 2 | $36 |
| AstraZeneca Pharmaceuticals LP | 1 | $26 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $19 |
| Paratek Pharmaceuticals, Inc. | 1 | $17 |
Products named: DUPIXENT, NUCALA, Hizentra, Andembry, Sunosi, XYWAV, Xhance, TEZSPIRE.
Industry payments across NY — which companies pay providers there.
